About Alan

Alan’s practice focuses on the representation of biotech, pharma, medical device and other life sciences companies in connection with technology-driven strategic transactions. He advises companies on research collaborations and development agreements, intellectual property and technology licensing agreements, and commercial collaborations, including joint ventures, profit-sharing arrangements and co-promotion agreements. He also has experience with manufacturing, distribution, supply and quality agreements, clinical trial agreements, M&A transactions, and life sciences industry-specific matters and counseling.

View full bio

Experience

Tourmaline Bio Enters Into Agreement to be Acquired by Novartis

Tourmaline Bio Enters Into Agreement to be Acquired by Novartis

September 9, 2025

Read more

Related contacts

Bill Sorabella
Partner, New York
Brandon W. Fenn
Partner, New York
Natalie D. Vernon
Associate, Colorado
Sangitha Palaniappa
Associate, Palo Alto
Katherine Denby
Special Counsel, Washington, DC
Pengli Li
Associate, Boston
Nyron J. Persaud
Partner, New York
Megan Browdie
Partner, Washington, DC
Anne Luquette
Associate, San Francisco
Brittany Sanok
Associate, New York
Annie Froehlich
Partner, Washington, DC
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
Christopher Kimball
Partner, Washington, DC
Eileen Marshall
Partner, Washington, DC
Carly Mitchell
Partner, Washington, DC
Phil Mitchell
Partner, New York
Ryan Montgomery
Partner, Boston
John Paul Oleksiuk
Partner, New York
Alan W. Tamarelli
Partner, New York
Dr. Michael Tuscan
Partner, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Andrew Epstein
Special Counsel, Seattle
J. Brian Stalter
Special Counsel, New York

Related Practices & Industries

Mergers and Acquisitions
Capital Markets
Biotechnology
Compensation and Benefits
Life Sciences Corporate Partnering and Licensing
Antitrust and Competition
Labor and Employment
Cyber/Data/Privacy
Tax
Trademark, Copyright and Advertising
Life Sciences and Healthcare Regulatory
Life Sciences
Commercial Litigation
Patent Counseling and Prosecution
Intellectual Property

Hengrui Pharma and Braveheart Bio Enter Into Exclusive License Agreement

Hengrui Pharma and Braveheart Bio Enter Into Exclusive License Agreement

September 5, 2025

Cooley advised Hengrui Pharma, a global pharmaceutical company, on its exclusive license agreement with Braveheart Bio for HRS-1893, a small-molecule inhibitor of cardiac myosin independently developed by Hengrui Pharma with best-in-class potential.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Freddy Yip
Associate, Hong Kong
Steve Przesmicki
Partner, San Diego
Navya Dasari
Associate, New York
Max Levinbook
Associate, San Diego
Jeffrey J. Tolin
Partner, New York
Amanda Pacheco
Associate, Palo Alto
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Zhijing Yu
Associate, Singapore
Christopher Kimball
Partner, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Rachel Thorn
Of counsel, New York
Karen Tsai
Special Counsel, Washington, DC

Related Practices & Industries

Life Sciences Corporate Partnering and Licensing
Life Sciences
Healthcare
Biotechnology
Tax
Antitrust and Competition
Cyber/Data/Privacy
CFIUS
Business Restructuring
Commercial Litigation
Asia

Hengrui Pharma and GSK Enter Agreement to Develop up to 12 Medicines

Hengrui Pharma and GSK Enter Agreement to Develop up to 12 Medicines

July 27, 2025

Cooley advised Hengrui Pharma, a global pharmaceutical company, on its up to $12.5 billion agreement with GSK to develop up to 12 medicines to complement GSKs extensive respiratory, immunology and inflammation (RI&I) and oncology pipeline.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Frances Stocks Allen
Partner, London
Jiqiang Lin
Associate, New York
Freddy Yip
Associate, Hong Kong
Aaron Pomeroy
Partner, Colorado
David Wilson
Partner, London
Dr. Xiaozhen (Shawn) Yu
Partner, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Robert Eisenbach
Of Counsel, San Francisco
Navya Dasari
Associate, New York
Rick Jantz
Associate, Santa Monica
Eerik Kukebal
Associate, London
Daniel Millard
Associate, London
Patrick Sharma
Associate, Santa Monica
Zhijing Yu
Associate, Singapore

Related Practices & Industries

Life Sciences Corporate Partnering and Licensing
Life Sciences
Healthcare
Biotechnology
Life Sciences and Healthcare Regulatory
Tax
Cyber/Data/Privacy
Business Restructuring
Antitrust and Competition
Patent Counseling and Prosecution
Asia

Somite AI Announces $47 Million Series A

Somite AI Announces $47 Million Series A

June 11, 2025

Cooley advised Somite AI, a techbio company leveraging foundation models and proprietary artificial intelligence to accelerate human cell therapy development, on the close of its $47 million Series A.

Read more

Related contacts

Stephane Levy
Partner, New York
Andrew Gunther
Associate, New York
Liz Gold
Associate, New York
Caolinn Mejza
Associate, New York
Mika Reiner Mayer
Partner, Palo Alto
Alan W. Tamarelli
Partner, New York
Jonathan Rivinus
Partner, Colorado
Calvin Lee
Associate, New York
Kevin Gurley
Quantitative Analyst, New York

Related Practices & Industries

Emerging Companies
Life Sciences
Healthcare
Biotechnology
Artificial Intelligence
Technology
Patent Counseling and Prosecution
Tax
Technology Transactions

Sirius Therapeutics Announces Collaboration With CRISPR Therapeutics

Sirius Therapeutics Announces Collaboration With CRISPR Therapeutics

May 19, 2025

Cooley advised Sirius Therapeutics, a clinical-stage biotech company developing innovative small interfering RNA (siRNA) therapies for global markets, on its strategic partnership to develop and commercialize siRNA therapies with CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Jiqiang Lin
Associate, New York
Navya Dasari
Associate, New York
Aaron Pomeroy
Partner, Colorado
Todd Gluth
Partner, San Diego
Rick Jantz
Associate, Santa Monica
Steve Przesmicki
Partner, San Diego
Robert Eisenbach
Of Counsel, San Francisco
Rachel Thorn
Of counsel, New York
David Burns
Special Counsel, Washington, DC
Eileen Marshall
Partner, Washington, DC
Jonathan Rivinus
Partner, Colorado

Related Practices & Industries

Life Sciences Corporate Partnering and Licensing
Life Sciences
Healthcare
Biotechnology
Tax
Capital Markets
Business Restructuring
Commercial Litigation
Antitrust and Competition
View more

Admissions and credentials

Massachusetts

New York

Pennsylvania

Rankings and accolades

Legal 500 US: Recommended for Commercial Deals and Contracts (2018)

Legal 500 US: Recommended for Technology Transactions (2018)